MedTrace Logo

The Influence of Oral Probiotics on the Microbiome and Lipidome

NCT03605108 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-06-12

No results posted yet for this study

Summary

The purpose of this study is to measure oil production of the face, facial properties, and gut bacteria in people being given oral probiotics. Probiotic supplements contain active cultures of bacteria that are thought to be beneficial to human health.The investigators want to find out if probiotics taken by mouth alter the bacteria in subject's gut and subject's skin oil production compared to a placebo. This is a single blind study and subject may receive a probiotic or a placebo for the first half of the study and a placebo or a probiotic for the second half of the study. Subject will not know what was given to participants.

Conditions

  • Gut Microbiome
  • Skin Microbiome
  • Gut Lipidome
  • Skin Lipidome
  • Blood Lipidome

Interventions

DIETARY_SUPPLEMENT

Probiotic

• Probiotic fomula per capsule: * 2 Billion CFUs * HU36 - 30 mg * HU58 - 20 mg * Bacillus clausii -25 mg * Bacillus coagulans 10B - 35 mg * Prepro - 22 mg. The prebiotic that is to be used in the proprietary blend is a vegetable grade cellulose.

OTHER

Placebo

Rice flour only

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Raja K. Sivamani, MD · UC Davis

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-29
Primary Completion
2019-05-09
Completion
2019-05-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03605108 on ClinicalTrials.gov